Genetic variation of Omi/HtrA2 and Parkinson's disease

Owen A. Ross, Alexandra I. Soto, Carles Vilariño-Güell, Michael G. Heckman, Nancy N. Diehl, Mary M. Hulihan, Jan O. Aasly, Sigrid Sando, J. Mark Gibson, Timothy Lynch, Anna Krygowska-Wajs, Grzegorz Opala, Maria Barcikowska, Krzysztof Czyzewski, Ryan J. Uitti, Zbigniew K. Wszolek, Matthew J. Farrer

Research output: Contribution to journalArticlepeer-review

56 Scopus citations


Variants in the Omi/HtrA2 gene have been nominated as a cause of Parkinson's disease. This sequencing study of Omi/HtrA2 in 95 probands with apparent autosomal dominant inheritance of Parkinson's disease did not identify any pathogenic mutations. In addition, there was no association between common variations in the Omi/HtrA2 gene and susceptibility to Parkinson's disease in any of our four patient-control series (n = 2373). Taken together our results do not support a role for Omi/HtrA2 variants in the pathogenesis of Parkinson's disease.

Original languageEnglish (US)
Pages (from-to)539-543
Number of pages5
JournalParkinsonism and Related Disorders
Issue number7
StatePublished - Nov 2008


  • HtrA2
  • Mitochondria
  • Neurodegeneration
  • PARK13
  • PD

ASJC Scopus subject areas

  • Neurology
  • Geriatrics and Gerontology
  • Clinical Neurology


Dive into the research topics of 'Genetic variation of Omi/HtrA2 and Parkinson's disease'. Together they form a unique fingerprint.

Cite this